Mutations in OCM genes such as MTHFR 677, MTHFR 1298, and DHFR 19bp impair the folate-mediated pathway, resulting in aberrant DNA methylation and synthesis, which raises the risk of breast cancer [45]. This evidence concerns the gene MTHFR and breast cancer.